108 related articles for article (PubMed ID: 12408963)
1. Identification of FOXC1 as a TGF-beta1 responsive gene and its involvement in negative regulation of cell growth.
Zhou Y; Kato H; Asanoma K; Kondo H; Arima T; Kato K; Matsuda T; Wake N
Genomics; 2002 Nov; 80(5):465-72. PubMed ID: 12408963
[TBL] [Abstract][Full Text] [Related]
2. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
Allen RR; Qi L; Higgins PJ
J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
Heegaard AM; Xie Z; Young MF; Nielsen KL
J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625
[TBL] [Abstract][Full Text] [Related]
4. Activin A inhibits growth-inhibitory signals by TGF-beta1 in differentiated human endometrial adenocarcinoma cells.
Tanaka T; Toujima S; Umesaki N
Oncol Rep; 2004 Apr; 11(4):875-9. PubMed ID: 15010888
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells.
Benckert C; Jonas S; Cramer T; Von Marschall Z; Schäfer G; Peters M; Wagner K; Radke C; Wiedenmann B; Neuhaus P; Höcker M; Rosewicz S
Cancer Res; 2003 Mar; 63(5):1083-92. PubMed ID: 12615726
[TBL] [Abstract][Full Text] [Related]
7. The wing 2 region of the FOXC1 forkhead domain is necessary for normal DNA-binding and transactivation functions.
Murphy TC; Saleem RA; Footz T; Ritch R; McGillivray B; Walter MA
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2531-8. PubMed ID: 15277473
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
[TBL] [Abstract][Full Text] [Related]
10. Effect of suppression of TGF-beta1 expression on cell-cycle and gene expression of beta-1,4-galactosyltransferase 1 in human hepatocarcinoma cells.
Zhang SW; Lin WS; Ying XL; Zhu D; Guo MY; Gu JX
Biochem Biophys Res Commun; 2000 Jul; 273(3):833-8. PubMed ID: 10891333
[TBL] [Abstract][Full Text] [Related]
11. Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines.
Kloth JN; Fleuren GJ; Oosting J; de Menezes RX; Eilers PH; Kenter GG; Gorter A
Carcinogenesis; 2005 Sep; 26(9):1493-502. PubMed ID: 15878915
[TBL] [Abstract][Full Text] [Related]
12. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
13. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S
Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950
[TBL] [Abstract][Full Text] [Related]
14. Nkx2.1 transcription factor in lung cells and a transforming growth factor-beta1 heterozygous mouse model of lung carcinogenesis.
Kang Y; Hebron H; Ozbun L; Mariano J; Minoo P; Jakowlew SB
Mol Carcinog; 2004 Aug; 40(4):212-31. PubMed ID: 15264213
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional analyses of disease-causing missense mutations in the forkhead domain of FOXC1.
Saleem RA; Banerjee-Basu S; Berry FB; Baxevanis AD; Walter MA
Hum Mol Genet; 2003 Nov; 12(22):2993-3005. PubMed ID: 14506133
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling.
Kutz SM; Higgins CE; Samarakoon R; Higgins SP; Allen RR; Qi L; Higgins PJ
Exp Cell Res; 2006 Apr; 312(7):1093-105. PubMed ID: 16457817
[TBL] [Abstract][Full Text] [Related]
17. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
18. Induction of human LTBP-3 promoter activity by TGF-beta1 is mediated by Smad3/4 and AP-1 binding elements.
Kantola AK; Keski-Oja J; Koli K
Gene; 2005 Dec; 363():142-50. PubMed ID: 16223572
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts.
Rosenthal E; McCrory A; Talbert M; Young G; Murphy-Ullrich J; Gladson C
Mol Carcinog; 2004 Jun; 40(2):116-21. PubMed ID: 15170816
[TBL] [Abstract][Full Text] [Related]
20. Identification of Tgf beta1i4 as a downstream target of Foxc1.
Sommer P; Napier HR; Hogan BL; Kidson SH
Dev Growth Differ; 2006 Jun; 48(5):297-308. PubMed ID: 16759280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
